Company · CIK 0001659617 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Moleculin Biotech, Inc. · MBRX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 3, 2026 PForm 4 → | Aug 5, 4:16 pm EDT | Jonathan P. FosterChief Financial Officer | 293,333 | — | — | 305,673 | — | |
| Aug 3, 2026 PForm 4 → | Aug 5, 4:16 pm EDT | Walter V KlempCEO and President, Director | 533,333 | — | — | 564,340 | — | |
| Aug 3, 2026 PForm 4 → | Aug 5, 4:15 pm EDT | Donald H PickerChief Science Officer | 173,333 | — | — | 174,086 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 3, 2026 PForm 4 → | Aug 5, 4:16 pm EDT | Jonathan P. FosterChief Financial Officer | 879,999 | — | — | 1,027,717 | — | |
| Aug 3, 2026 AForm 4 → | Aug 5, 4:16 pm EDT | Walter V KlempCEO and President, Director | 1,599,999 | — | — | 1,926,335 | — | |
| Aug 3, 2026 PForm 4 → | Aug 5, 4:15 pm EDT | Donald H PickerChief Science Officer | 519,999 | — | — | 539,595 | — |